Products

MoleculePresentationStatusTherapeutic Area
Alendronic acid  70 mg x   2 tabletsMA and DossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
 70 mg x   4 tablets
 70 mg x   8 tablets
 70 mg x  12 tablets
 70 mg x   40 tablets
Amoxicillin1 g  12 tabletsMA and DossierANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN
Amoxicillin and clavulanic acid875 + 125 mg  tablets and sachetsMA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - PENICILLIN IN ASSOCIATION
Amoxicillin and clavulanic acidPediatric sachetsUnder development
Apixaban2,5 mg x 60 film coated tabletsUnder registrationANTITHROMBOTIC DRUGS - 
 5 mg x 60 film coated tablets
Atorvastatin10 mg x 30 tabletsMA  and DossierMODIFYING SUBSTANCE OF LIPIDS -
HMG-CoA REDUCTASE INHIBITOR - (STATIN)
 20 mg x 30 tablets
 30 mg x 28 tablets
 40 mg x 30 tablets 
 60 mg x 28 tablets
 80 mg x 30 tablets
Calcium Levofolinate7,5 mg x 10 tabletsDossier submittedTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE
    4 mg x 30 tablets
Calcium Levofolinate Lyophilized 25 mg vialMA  and DossierTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE
 100 mg vial
 175 mg vial
Calcium Levofolinate solution25 mg/2,5 ml vialMA  and DossierTHERAPEUTIC PRODUCT - DETOXIFYING SUBSTANCE FOR ANTINEOPLASTIC TREATMENTS -ANTIDOTE
 50 mg/ 5 ml vial
 100 mg/10 ml vial
 175 mg/17,5 ml vial
Cefazolina1000 mg/4 ml powder and solvent for injectable solution i.m.MA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - CEPHALOSPORINE OF FIRST GENERATION
Ceftriaxone 250 mg/ 2 ml - powder and solvent for injectable solution i.m.MA  and DossierANTIBACTERIAL FOR SYSTEMIC USE - THIRD-GENERATION CEPHALOSPORINE
 500 mg/ 2 ml - powder and solvent for injectable solution i.m.
 1 gr/3,5 ml -  powder and solvent for injectable solution i.m.
 1 g / 10 ml powder and solvent  for injectabble solution e.v.
 2 g  powder for solution for infusion
Cilostazole100 mg x 28 tabletsMA  and DossierANTITHROMBOTIC
PLASTIC ANTI-AGING
Ciprofloxacin250 mg x  10 tabletsMA  and DossierANTIBACTERIALS FOR SYSTEMIC USE - KINOLONIC ANTIBACTERIALS
 500 mg x  6 tablets
  750 mg x 12 tablets
Citalopram drops40 mg/mlDossierANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)
Clodronic Acid + lidocaine100 mg / 3,3 ml 6 vialsDossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
 200 mg/ 4 ml 3 vials 
Dabigatran110 mg x 60 capsulesUnder registrationANTITHROMBOTIC AGENTS, DIRECT THROMBIN INHIBITORS
 110 mg x 30 capsules
 110 mg x 10 capsules
 150 mg x 60 capsules
 75 mg x 30 capsules
 75 mg x 10 capsules
Desketoprofene25 mg 20 tabletsMA  and DossierANTI-INFLAMMATORY AND ANTIREHUMATIC,  NOT STEROID
  25 mg oral solution stick pack
Dutasteride0,5 mg x 30 capsulesMA  and DossierDRUG USED IN BENIGNA PROSTATIC HYPERTROPHY
Dutasteride and Tamsulosin0,5 mg/0,4 mg x 30 and 90 capsulesMA  and Dossier 
Escitalopram drops20 mg /ml -  bottle 15 mlMA  and DossierANTIDEPRESSANT -
SELECTIVE SEROTONIN REUPTAKE INHIBITORS (SSRI)
Finasteride 1 mg x 28 tabletsMA  and DossierDRUG USED FOR STATES OF ANDROGENETIC ALOPECIA IN MEN
 5 mg x 15 tabletsDRUG USED IN BENIGNA PROSTATIC HYPERTROPHY 
Fosfomycin Trometamol 3 g granular for solution -  2 sachetsMA  and DossierANTIBACTERIAL FOR SYSTEMIC USE 
Furosemide  25 mg x 30 tablets Dossier under submissionDIURETIC - DIURETIC FOR HIGHER DIURETIC ACTION -
NON-ASSOCIATED SULPHONAMID
Furosemide500 mg x 20 tablets
Ibandronate150 mg x  3 tabletsMA  and DossierFOR THE TREATMENT OF BONE DISEASE - BISPHOSPHONATE
Manidipine10 mg x  28 tabletsMA and DossierCALCIUM-ANTAGONIST
 20 mg x 28  tablets
Metformina500 mg, 30-50 tablets MA and Dossier FOR THE TREATMENT OF TYPE 2 DIABETES - BIGUANIDE
 850 mg, 30-40 tablets
 1000 mg, 60 tablets
Nebivolole  5 mg x  28 tabletsMA  and DossierSELECTIVE BETA BLOCKER -
FOR THE TREATMENT OF HYPERTENSION
Omeprazole10 mg x 14-28 capsulesMA  and DossierFOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs)
 20 mg x 14-28 capsules
 40 mg x 14-28 capsules
Pantoprazole (OTC)20 mg x 7 - 14 tabletsMA and DossierFOR DISORDERS RELATED TO ACID SECRETION - FOR THE TREATMENT OF PEPTIC ULCER AND GASTROESOGACEOUS REFLUX DISEASE -
PROTON-PUMP INHIBITORS (PPIs)
Paroxetine drops10 mg/ml oral drops, solutionMA end DossierANTIDEPRESSANT -SELECTIVE SEROTONIN REUPTAKE INHIBITOR (SSRI)
Prednisone  5 mg x 20 tabletsMA  and DossierSYSTEMIC CORTICOSTEROID - GLUCOCORTICOID
   5 mg x 10 tablets
 25 mg x 10 tablets
Rivaroxaban10 mg x 30 film coated tabletsUnder registrationANTITHROMBOTIC DRUGS - DIRECT FACTOR XA INHIBITORS
 15 mg x 42 film coated tablets
 20 mg x 28 film coated tablets
Sitagliptin25 mg x 28 film coated tabletsUnder registrationORAL HYPOGLYCEMIC AGENTS DRUGS USED IN DIABETES, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS
 25 mg x 56 film coated tablets
 50 mg x 28 film coated tablets
 50 mg x 56 film coated tablets
 100 mg x 28 film coated tablets
 100 mg x 56 film coated tablets
Sitagliptin + metformina50 mg + 850 mg x 56 film coated tabletsUnder registrationDRUGS USED IN DIABETES, ORAL HYPOGLYCEMIC DRUG COMBINATIONS
 50 mg + 1000 mg x 56 film coated tablets
Vildagliptin50 mg x 56 film coated tabletsUnder registrationORAL HYPOGLYCEMIC AGENTS DRUGS USED IN DIABETES, DIPEPTIDYL PEPTIDASE 4 (DPP-4) INHIBITORS
 50 mg x 28 film coated tablets
Vildagliptin + metformina50 mg + 850 mg x 60 film coated tabletsUnder registrationDRUGS USED IN DIABETES, ORAL HYPOGLYCEMIC DRUG COMBINATIONS
 50 mg + 1000 mg x 60 film coated tablets
VITAMIN D3soft gel capsules:   10.000 U.I.Dossier ready, MA under approvalVITAMIN D
 soft gel capsules:   25.000 U.I.
 soft gel capsules:   50.000 U.I.
 soft gel capsules: 100.000 U.I.
 injectable: 100.000 U.I.
 injectable: 300.000 U.I.
Zolpidem 10 mg/ml, oral drops, solution , bottle 30 mlUnder developmentBENZODIAZEPINE-RELATED DRUGS